162 related articles for article (PubMed ID: 25906747)
1. The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers.
Ong CW; Chong PY; McArt DG; Chan JY; Tan HT; Kumar AP; Chung MC; Clément MV; Soong R; Van Schaeybroeck S; Waugh DJ; Johnston PG; Dunne PD; Salto-Tellez M
Oncotarget; 2015 May; 6(14):12763-73. PubMed ID: 25906747
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.
Xu F; Li S; Zhang J; Wang L; Wu X; Wang J; Huang Q; Lai M
Clin Colorectal Cancer; 2018 Sep; 17(3):e579-e592. PubMed ID: 29921496
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
[TBL] [Abstract][Full Text] [Related]
5. Colorectal micropapillary carcinomas are associated with poor prognosis and enriched in markers of stem cells.
Lee HJ; Eom DW; Kang GH; Han SH; Cheon GJ; Oh HS; Han KH; Ahn HJ; Jang HJ; Han MS
Mod Pathol; 2013 Aug; 26(8):1123-31. PubMed ID: 23060121
[TBL] [Abstract][Full Text] [Related]
6. mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.
Chang JY; Kim JH; Kang J; Park Y; Park SJ; Cheon JH; Kim WH; Kim H; Park JJ; Kim TI
Yonsei Med J; 2020 Jul; 61(7):572-578. PubMed ID: 32608200
[TBL] [Abstract][Full Text] [Related]
7. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.
Lundberg IV; Edin S; Eklöf V; Öberg Å; Palmqvist R; Wikberg ML
BMC Cancer; 2016 Jul; 16():471. PubMed ID: 27411517
[TBL] [Abstract][Full Text] [Related]
8. Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer.
Kleist B; Xu L; Li G; Kersten C
Int J Clin Exp Pathol; 2011 Apr; 4(4):327-35. PubMed ID: 21577318
[TBL] [Abstract][Full Text] [Related]
9. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
[TBL] [Abstract][Full Text] [Related]
11. High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.
Hanke T; Melling N; Simon R; Sauter G; Bokemeyer C; Lebok P; Terracciano LM; Izbicki JR; Marx AH
Int J Clin Exp Pathol; 2015; 8(7):8227-35. PubMed ID: 26339391
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
Buhmeida A; Bendardaf R; Hilska M; Collan Y; Laato M; Syrjänen S; Syrjänen K; Pyrhönen S
J Gastrointest Cancer; 2009; 40(3-4):91-7. PubMed ID: 19921474
[TBL] [Abstract][Full Text] [Related]
13. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
15. Detection of cancer stem cell-related markers in different stages of colorectal carcinoma patients of Indian origin by immunohistochemistry.
Chaitra LP; Prashant A; Gowthami CS; Hajira B; Suma MN; Mahesh SS; Manjunath GV; Sheeladevi CS
J Cancer Res Ther; 2019; 15(1):75-81. PubMed ID: 30880758
[TBL] [Abstract][Full Text] [Related]
16. Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer.
Pelli A; Väyrynen JP; Klintrup K; Mäkelä J; Mäkinen MJ; Tuomisto A; Karttunen TJ
Histopathology; 2016 Nov; 69(5):831-838. PubMed ID: 27257976
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.
Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Fukuta F; Masumori N; Sato N; Tsukamoto T
Mod Pathol; 2013 Jan; 26(1):117-24. PubMed ID: 22899292
[TBL] [Abstract][Full Text] [Related]
18. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
[TBL] [Abstract][Full Text] [Related]
19. AC133 expression associated with poor prognosis in stage II colorectal cancer.
Ying X; Wu J; Meng X; Zuo Y; Xia Q; Chen J; Feng Y; Liu R; Li L; Huang W
Med Oncol; 2013 Mar; 30(1):356. PubMed ID: 23322518
[TBL] [Abstract][Full Text] [Related]
20. Hierarchical clustering analysis of pathologic and molecular data identifies prognostically and biologically distinct groups of colorectal carcinomas.
Furlan D; Carnevali IW; Bernasconi B; Sahnane N; Milani K; Cerutti R; Bertolini V; Chiaravalli AM; Bertoni F; Kwee I; Pastorino R; Carlo C
Mod Pathol; 2011 Jan; 24(1):126-37. PubMed ID: 20852594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]